Jessica Goza, NP
Nurse Practitioner · Napa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Spectrumcare Rehabilitation Medical · 3 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Jessica Goza’s office at (707) 252-9660 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$75,561
Medicare paid this office $75,561 for 160 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 146 | $41,272 | $53 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 104 | $4,320 | $11 |
| Short return visit | 17 | $779 | $35 |
Who their Medicare patients are
160 Original Medicare patients in 2024. Average age 71 · Women 57% · Also on Medicaid 19% · Health risk score 1.15. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 65% · Diabetes 23% · Depression 23% · Coronary heart disease 19% · COPD 18% · Chronic kidney disease 16% · Atrial fibrillation 13% · Heart failure 10% · Cancer 9% · Stroke 7%.
The office billed $177,499, Medicare allowed $104,069 and paid $75,561; for 6,152 services of 16 kinds; $23,983 of it was for drugs given in the office and $51,577 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 160 | 6,152 | 71 | 1.15 | $177,499 | $75,561 |
| 2023 | 143 | 2,487 | 71 | 1.36 | $126,503 | $55,747 |
| 2022 | 159 | 1,058 | 70 | 1.25 | $243,714 | $106,642 |
| 2021 | 253 | 640 | 73 | 0.93 | $118,071 | $40,450 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Short return visit (20+ min) | 132 | $37,868 | $55 |
| Testing for presence of drug, by chemistry analyzers | 35 | $2,758 | $60 |
| Short return visit | 21 | $972 | $34 |
2022: 4 services
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 93 | $49,699 | $244 |
| Return visit (30+ min) | 112 | $24,752 | $85 |
| Testing for presence of drug, by chemistry analyzers | 118 | $21,769 | $61 |
| Short return visit (20+ min) | 88 | $8,736 | $63 |
2021: 4 services
| Return visit (30+ min) | 163 | $23,249 | $81 |
| Short return visit (20+ min) | 115 | $9,154 | $59 |
| New patient visit (45+ min) | 37 | $3,364 | $91 |
| New patient visit (30+ min) | 13 | $689 | $53 |
Medicaid work
$56,757 in 2024
Medicaid paid $56,757 for 2,055 billed services this clinician did in 2024, up to 87 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 891 | $49,428 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 490 | $4,858 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 674 | $2,471 |
| 2024 | 2,055 | 3 | 87 | $56,757 |
| 2023 | 1,362 | 3 | 93 | $41,059 |
| 2022 | 664 | 5 | 68 | $21,928 |
| 2021 | 1,588 | 10 | 39 | $16,908 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 840 | $37,822 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 50 | $2,079 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 472 | $1,158 |
2022
| Return visit (30+ min) | 158 | $8,967 |
| Short return visit (20+ min) | 138 | $6,543 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 113 | $5,421 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 226 | $658 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 29 | $339 |
2021
| Return visit (30+ min) | 340 | $12,601 |
| Short return visit (20+ min) | 145 | $4,306 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 200 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 155 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 144 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 86 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 30 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 17 | $0 |
| Bmi is documented within normal parameters and no follow-up plan is required | 144 | $0 |
| Bmi is documented above normal parameters and a follow-up plan is documented | 327 | $0 |
Drugs they prescribed that Part D paid
$258,231
Pharmacies billed $258,231 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 50% of their Part D prescriptions (1,722 of 3,431) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%. Long-acting opioids: 4% of their opioid prescriptions.
3,264 generic and 167 brand-name prescriptions · $258,231 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Nurtec Odt | None | 62 | $91,056 | $1,469 |
| Botox | None | 30 | $38,724 | $1,291 |
| Hydrocodone-Acetaminophen | None | 643 | $17,806 | $28 |
| Belbuca | None | 13 | $13,492 | $1,038 |
| Aimovig | Migraine | 15 | $12,532 | $835 |
See all 35 drugs
| Nurtec Odt | None | 62 | $91,056 | $1,469 |
| Botox | None | 30 | $38,724 | $1,291 |
| Hydrocodone-Acetaminophen | None | 643 | $17,806 | $28 |
| Belbuca | None | 13 | $13,492 | $1,038 |
| Aimovig | Migraine | 15 | $12,532 | $835 |
| Emgality | Migraine | 17 | $12,326 | $725 |
| Buprenorphine-Naloxone | None | 45 | $9,055 | $201 |
| Oxycodone | None | 600 | $7,671 | $13 |
| Oxycodone-Acetaminophen | None | 253 | $6,394 | $25 |
| Pregabalin | None | 289 | $6,347 | $22 |
| Lidocaine | None | 60 | $6,265 | $104 |
| Buprenorphine | None | 87 | $3,977 | $46 |
| Gabapentin | None | 174 | $3,683 | $21 |
| Cyclobenzaprine | None | 160 | $2,030 | $13 |
| Diclofenac | None | 30 | $1,794 | $60 |
| Baclofen | None | 142 | $1,605 | $11 |
| Methocarbamol | None | 72 | $1,223 | $17 |
| Tramadol | None | 98 | $1,014 | $10 |
| Celecoxib | None | 43 | $900 | $21 |
| Tizanidine | None | 77 | $879 | $11 |
| Morphine Sulfate Er | None | 27 | $849 | $31 |
| Hydroxyzine | None | 15 | $663 | $44 |
| Ibuprofen | None | 49 | $662 | $14 |
| Acetaminophen-Codeine | None | 42 | $615 | $15 |
| Duloxetine | None | 16 | $510 | $32 |
| Sumatriptan | None | 21 | $356 | $17 |
| Ondansetron Odt | None | 16 | $319 | $20 |
| Meloxicam | None | 35 | $311 | $9 |
| Trazodone | None | 20 | $188 | $9 |
| Zolpidem | None | 21 | $174 | $8 |
| Hydromorphone | None | 17 | $145 | $9 |
| Methylprednisolone | None | 14 | $120 | $9 |
| Diazepam | None | 43 | $95 | $2 |
| Alprazolam | None | 15 | $10 | $1 |
| Lorazepam | None | 13 | $7 | $1 |
Year by year
| 2024 | 3,431 | 285 | 50% (1,722) | 5% | $258,231 |
| 2023 | 2,950 | 281 | 50% (1,479) | 4% | $200,965 |
| 2022 | 3,108 | 415 | 43% (1,338) | None | $154,541 |
| 2021 | 1,148 | 261 | 3% (36) | None | $120,256 |
| 2020 | 910 | 72 | 38% (344) | 9% | $74,221 |
| 2019 | 497 | 78 | 64% (319) | 13% | $46,676 |
| 2018 | 414 | 81 | 70% (291) | 10% | $30,190 |
| 2017 | 353 | 71 | 38% (135) | 12% | $24,465 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 30 drugs
| Nurtec Odt | None | 38 | $60,015 | $1,579 |
| Hydrocodone-Acetaminophen | None | 630 | $18,873 | $30 |
| Aimovig | Migraine | 18 | $16,525 | $918 |
| Buprenorphine-Naloxone | None | 52 | $15,293 | $294 |
| Lidocaine | None | 63 | $8,882 | $141 |
| Pregabalin | None | 233 | $7,425 | $32 |
| Oxycodone | None | 484 | $6,688 | $14 |
| Diclofenac | None | 59 | $5,282 | $90 |
| Oxycodone-Acetaminophen | None | 214 | $3,725 | $17 |
| Gabapentin | None | 163 | $3,352 | $21 |
| Buprenorphine | None | 52 | $2,266 | $44 |
| Cyclobenzaprine | None | 117 | $1,677 | $14 |
| Baclofen | None | 91 | $1,235 | $14 |
| Tizanidine | None | 75 | $942 | $13 |
| Tramadol | None | 69 | $766 | $11 |
| Hydroxyzine | None | 15 | $629 | $42 |
| Meloxicam | None | 76 | $482 | $6 |
| Methocarbamol | None | 44 | $401 | $9 |
| Acetaminophen-Codeine | None | 30 | $373 | $12 |
| Ibuprofen | None | 33 | $349 | $11 |
| Trazodone | None | 37 | $336 | $9 |
| Diazepam | None | 33 | $246 | $7 |
| Zolpidem | None | 46 | $243 | $5 |
| Hydromorphone | None | 17 | $209 | $12 |
| Duloxetine | None | 12 | $184 | $15 |
| Methylprednisolone | None | 12 | $107 | $9 |
| Ondansetron Odt | None | 17 | $93 | $5 |
| Nortriptyline | None | 11 | $91 | $8 |
| Carisoprodol | None | 12 | $67 | $6 |
| Alprazolam | None | 17 | $18 | $1 |
2022: 36 drugs
| Hydrocodone-Acetaminophen | None | 613 | $17,451 | $28 |
| Lidocaine | None | 44 | $9,271 | $211 |
| Buprenorphine-Naloxone | None | 50 | $9,224 | $184 |
| Pregabalin | None | 204 | $9,044 | $44 |
| Aimovig | Migraine | 11 | $8,046 | $731 |
| Oxycodone-Acetaminophen | None | 271 | $7,794 | $29 |
| Oxycodone | None | 282 | $6,361 | $23 |
| Diclofenac | None | 62 | $5,503 | $89 |
| Gabapentin | None | 184 | $4,785 | $26 |
| Baclofen | None | 149 | $2,397 | $16 |
| Buprenorphine | None | 25 | $2,382 | $95 |
| Cyclobenzaprine | None | 141 | $1,913 | $14 |
| Tizanidine | None | 93 | $1,376 | $15 |
| Morphine Sulfate Er | None | 27 | $1,103 | $41 |
| Tramadol | None | 107 | $1,036 | $10 |
| Celecoxib | None | 16 | $874 | $55 |
| Levothyroxine | None | 27 | $625 | $23 |
| Trazodone | None | 28 | $494 | $18 |
| Ibuprofen | None | 31 | $424 | $14 |
| Meloxicam | None | 74 | $412 | $6 |
| Atorvastatin | None | 32 | $386 | $12 |
| Morphine Sulfate | None | 11 | $294 | $27 |
| Duloxetine | None | 12 | $286 | $24 |
| Omeprazole | None | 20 | $227 | $11 |
| Naproxen | None | 12 | $205 | $17 |
| Losartan | None | 15 | $185 | $12 |
| Metformin | None | 17 | $177 | $10 |
| Acetaminophen-Codeine | None | 15 | $176 | $12 |
| Metoprolol | None | 12 | $165 | $14 |
| Methocarbamol | None | 13 | $159 | $12 |
| Lisinopril | None | 34 | $152 | $4 |
| Hydrochlorothiazide | None | 24 | $140 | $6 |
| Diazepam | None | 31 | $139 | $4 |
| Methylprednisolone | None | 16 | $137 | $9 |
| Amlodipine Besylate | None | 15 | $90 | $6 |
| Zolpidem | None | 21 | $87 | $4 |
2021: 33 drugs
| Eliquis | 14 | $14,774 | $1,055 |
| Buprenorphine-Naloxone | 12 | $1,856 | $155 |
| Rosuvastatin | 17 | $1,275 | $75 |
| Levothyroxine | 47 | $1,054 | $22 |
| Omeprazole | 33 | $1,011 | $31 |
| Quetiapine | 17 | $1,003 | $59 |
| Duloxetine | 12 | $964 | $80 |
| Gabapentin | 42 | $888 | $21 |
| Tamsulosin | 17 | $881 | $52 |
| Albuterol Sulfate Hfa | 14 | $725 | $52 |
| Atorvastatin | 40 | $706 | $18 |
| Lisinopril | 67 | $679 | $10 |
| Amlodipine Besylate | 33 | $465 | $14 |
| Baclofen | 14 | $454 | $32 |
| Losartan | 24 | $442 | $18 |
| Hydrocodone-Acetaminophen | 14 | $398 | $28 |
| Hydroxyzine | 15 | $386 | $26 |
| Metoprolol | 18 | $348 | $19 |
| Fluticasone Propionate | 17 | $337 | $20 |
| Allopurinol | 12 | $264 | $22 |
| Trazodone | 18 | $262 | $15 |
| Triamcinolone Acetonide | 16 | $206 | $13 |
| Cyclobenzaprine | 19 | $190 | $10 |
| Nitrofurantoin Mono-Macro | 11 | $188 | $17 |
| Tizanidine | 11 | $162 | $15 |
| Famotidine | 12 | $134 | $11 |
| Lisinopril-Hydrochlorothiazide | 14 | $129 | $9 |
| Naproxen | 12 | $125 | $10 |
| Hydrochlorothiazide | 17 | $122 | $7 |
| Mupirocin | 11 | $105 | $10 |
| Metformin | 20 | $76 | $4 |
| Simvastatin | 12 | $56 | $5 |
| Furosemide | 13 | $41 | $3 |
2020: 25 drugs
| Zubsolv | 45 | $21,992 | $489 |
| Buprenorphine | 23 | $11,292 | $491 |
| Buprenorphine-Naloxone | 59 | $11,182 | $190 |
| Belbuca | 11 | $9,936 | $903 |
| Hydrocodone-Acetaminophen | 159 | $3,487 | $22 |
| Diclofenac | 36 | $1,938 | $54 |
| Buprenorphine | 21 | $1,869 | $89 |
| Fentanyl | 19 | $1,807 | $95 |
| Oxycodone | 43 | $911 | $21 |
| Diclofenac | 14 | $587 | $42 |
| Duloxetine | 20 | $572 | $29 |
| Baclofen | 38 | $490 | $13 |
| Gabapentin | 58 | $487 | $8 |
| Morphine Sulfate Er | 13 | $466 | $36 |
| Cyclobenzaprine | 35 | $350 | $10 |
| Tizanidine | 37 | $302 | $8 |
| Bupropion Hcl Sr | 14 | $270 | $19 |
| Tramadol | 44 | $262 | $6 |
| Zolpidem | 26 | $199 | $8 |
| Omeprazole | 14 | $193 | $14 |
| Amitriptyline | 12 | $185 | $15 |
| Ibuprofen | 17 | $182 | $11 |
| Trazodone | 29 | $160 | $6 |
| Naproxen | 11 | $34 | $3 |
| Quetiapine | 14 | $26 | $2 |
2019: 13 drugs
| Zubsolv | 20 | $10,297 | $515 |
| Belbuca | 12 | $8,016 | $668 |
| Buprenorphine | 13 | $6,784 | $522 |
| Buprenorphine-Naloxone | 46 | $5,388 | $117 |
| Hydrocodone-Acetaminophen | 174 | $3,819 | $22 |
| Butalbital Compound-Codeine | 12 | $1,600 | $133 |
| Buprenorphine | 20 | $1,348 | $67 |
| Oxycodone | 26 | $666 | $26 |
| Oxycodone-Acetaminophen | 17 | $634 | $37 |
| Morphine Sulfate Er | 14 | $366 | $26 |
| Tramadol | 24 | $245 | $10 |
| Zolpidem | 14 | $208 | $15 |
| Gabapentin | 11 | $120 | $11 |
2018: 10 drugs
| Butrans | 17 | $11,597 | $682 |
| Hydrocodone-Acetaminophen | 136 | $3,539 | $26 |
| Oxycodone-Acetaminophen | 37 | $1,652 | $45 |
| Oxycodone | 21 | $939 | $45 |
| Morphine Sulfate Er | 12 | $565 | $47 |
| Gabapentin | 13 | $336 | $26 |
| Methadone | 17 | $222 | $13 |
| Zolpidem | 19 | $202 | $11 |
| Tramadol | 17 | $153 | $9 |
| Cyclobenzaprine | 12 | $119 | $10 |
2017: 11 drugs
| Oxycodone-Acetaminophen | 23 | $1,145 | $50 |
| Hydrocodone-Acetaminophen | 45 | $820 | $18 |
| Gabapentin | 32 | $372 | $12 |
| Duloxetine | 11 | $343 | $31 |
| Cyclobenzaprine | 16 | $255 | $16 |
| Oxycodone | 11 | $219 | $20 |
| Nortriptyline | 11 | $143 | $13 |
| Sumatriptan | 11 | $113 | $10 |
| Meloxicam | 11 | $101 | $9 |
| Tramadol | 11 | $96 | $9 |
| Trazodone | 15 | $92 | $6 |
Money from drug and device companies
$424 in 2025
| 2025 | 4 | 17 | None | $424 |
| 2024 | 7 | 24 | None | $716 |
| 2023 | 4 | 24 | None | $791 |
| 2022 | 2 | 16 | None | $350 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Qulipta | $250 | 9 payments
|
| Pfizer | Nurtec Odt | $109 | 5 payments
|
| Teva Pharmaceuticals USA | Ajovy | $41 | 2 payments
|
| Biotronik Nro | Prospera | $25 | 1 payment
|
See all 17 published payments
| Abbvie | Meals · 2025-12-09 | Qulipta | $26 |
| Pfizer | Meals · 2025-12-02 | Nurtec Odt | $21 |
| Abbvie | Meals · 2025-11-25 | Botox | $35 |
| Pfizer | Meals · 2025-10-07 | Nurtec Odt | $24 |
| Abbvie | Meals · 2025-09-10 | Qulipta | $20 |
| Abbvie | Meals · 2025-09-10 | Qulipta | $21 |
| Pfizer | Meals · 2025-08-28 | Nurtec Odt | $21 |
| Abbvie | Meals · 2025-08-20 | Qulipta | $31 |
| Teva Pharmaceuticals USA | Meals · 2025-07-30 | Ajovy | $25 |
| Abbvie | Meals · 2025-06-26 | Qulipta | $27 |
| Abbvie | Meals · 2025-06-05 | Ubrelvy | $31 |
| Pfizer | Meals · 2025-06-05 | Nurtec Odt | $28 |
| Abbvie | Meals · 2025-04-17 | Ubrelvy | $32 |
| Biotronik Nro | Meals · 2025-04-09 | Prospera | $25 |
| Pfizer | Meals · 2025-03-27 | Nurtec Odt | $15 |
| Teva Pharmaceuticals USA | Meals · 2025-03-25 | Ajovy | $16 |
| Abbvie | Meals · 2025-01-23 | Qulipta | $28 |
See earlier years (2024, 2023, 2022)
2024: $716
| Abbvie | Qulipta | $288 | 12 payments
|
| Saluda Medical Americas | Evoke | $186 | 1 payment
|
| Biotronik Nro | Prospera | $81 | 3 payments
|
| Pfizer | Nurtec Odt | $65 | 4 payments
|
| Bioventus | Durolane | $56 | 2 payments
|
| Lundbeck | Vyepti | $25 | 1 payment
|
| Teva Pharmaceuticals USA | Ajovy | $15 | 1 payment
|
2023: $791
| Abbvie | Qulipta | $548 | 18 payments
|
| Si-Bone | None | $134 | 1 payment
|
| Pfizer | Paxlovid | $81 | 4 payments
|
| Teva Pharmaceuticals USA | Ajovy | $29 | 1 payment
|
2022: $350
| Abbvie | Ubrelvy | $262 | 12 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $87 | 4 payments
|
Professional record
- NPI
- 1649710476
- Licence
- CA 95006244
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP2300X (363LP2300X)
- Mailing address
- 2494 Palmer Cir, Fairfield, CA, 94534
- NPI first listed
- 2017-02-27
- NPI last updated
- 2017-02-27
This is when the NPI record was last certified, not a medical board exam.